NFL, NFLPA Review Hurts Blood Clot Handling — SkimNews
Get the Sports newsletter
Daily sports — scores, transfers, the storylines from the leagues you actually follow. Free.
- NFL and the NFL Players Association said in a joint statement Sunday they are reviewing how Jalen Hurts' blood clot diagnosis was handled, following the union's call for an investigation earlier in the week.
- Jalen Hurts was placed on injured reserve and is expected to miss the rest of the season after a blood clot in his left calf traveled to his lungs.
- Nicole Lynn, Hurts' agent, and the Eagles said Monday that Hurts has deep vein thrombosis and bilateral pulmonary emboli; his treatment involves blood thinners that keep him out of all football activities until he comes off them.
- Philadelphia Eagles said Hurts was injured when he took a cleat to his calf area Oct. 4 against the Los Angeles Rams; he informed the medical staff after practice Oct. 8 and was back at practice the next day before the team left for London to play the Jacksonville Jaguars.
- London specialists initially diagnosed only a left calf superficial vein thrombosis, yet Hurts played against the Jacksonville Jaguars on Oct. 11.
- Roger Goodell said Wednesday the league welcomed the investigation after Dr. Allen Sills, its chief medical officer, gave a passionate defense of the Eagles' medical staff; Goodell said the chief medical officer went through the protocols and the league is comfortable they were followed.
Why it matters: The review puts the Eagles' medical timeline — injury reported Oct. 8, a London diagnosis, then a full game Oct. 11 — under joint league-union scrutiny. Goodell and chief medical officer Allen Sills already defend the protocols, while Hurts sits out the rest of the season on blood thinners, leaving Philadelphia without its Super Bowl LIX MVP.
Ask SkimNews
